Progress Toward Rationally Designed Small-Molecule Peptide and Peptidomimetic CXCR4 Antagonists
Citations Over TimeTop 24% of 2015 papers
Abstract
Over the last 5 years, X-ray structures of CXCR4 in complex with three different ligands (the small-molecule antagonist IT1t, the polypeptide antagonist CVX15 and the viral chemokine antagonist vMIP-II) have been released. In addition to the inherent scientific value of these specific X-ray structures, they provide a reliable structural foundation for studies of the molecular interactions between CXCR4 and its key peptide ligands (CXCL12 and HIV-1 gp120), and serve as valuable templates for further development of small-molecule CXCR4 antagonists with therapeutic potential. We here review recent computational studies of the molecular interactions between CXCR4 and its peptide ligands - based on the X-ray structures of CXCR4 - and the current status of small-molecule peptide and peptidomimetic CXCR4 antagonists.
Related Papers
- → Macrocyclization strategies for cyclic peptides and peptidomimetics(2021)189 cited
- → Improvement on Permeability of Cyclic Peptide/Peptidomimetic: Backbone N-Methylation as A Useful Tool(2021)44 cited
- → Recent Progress of Synthetic Studies to Peptide and Peptidomimetic Cyclization(2008)61 cited
- → Biphenyl-dihydrothiazole-cyclized peptide libraries for peptide ligand and drug discovery(2025)8 cited
- → Wheel of Fortune – Cyclic Peptides Hit the Mimetic Jackpot: Current Syntheses, Uses and Roles for Cyclic Peptide Mimetics(2015)1 cited